# RSHF in Colorectal Cancer

> **NCT01220063** · PHASE2 · COMPLETED · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 48 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **RADIATION:** Radiation
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT01220063
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-19
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220063, "RSHF in Colorectal Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01220063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*